Analysis of the pharmacological mechanisms of Xiaoyao pill in breast cancer treatment
In conclusion, the Xiaoyao pill holds promise in treating BRCA by down-regulating lipid metabolism pathways and potentially influencing tumor immunity, presenting a multifaceted approach to breast cancer management.
Authors
- Rutian Hao (ORCID: https://orcid.org/0000-0001-6567-7862)
- Adheesh Bhandari (ORCID: https://orcid.org/0000-0002-0406-2685)
- Yanyan Shen (ORCID: https://orcid.org/0000-0002-6615-7233)
- Xinyu Meng
- Jie Chen (ORCID: https://orcid.org/0009-0003-2727-0289)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1097/ms9.0000000000003276
- Primary Topic
- Medicinal Plant Pharmacodynamics Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00